These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

475 related items for PubMed ID: 3488858

  • 21. [Complement activation and inflammation].
    Abe M.
    Rinsho Byori; 2006 Jul; 54(7):744-56. PubMed ID: 16913666
    [Abstract] [Full Text] [Related]

  • 22. C3, C5 components and C3a, C4a, and C5a fragments of the complement system.
    Janatova J.
    Methods Enzymol; 1988 Jul; 162():579-625. PubMed ID: 3265757
    [No Abstract] [Full Text] [Related]

  • 23. Comparative structural anatomy of the complement anaphylatoxin proteins C3a, C4a and C5a.
    Greer J.
    Enzyme; 1986 Jul; 36(1-2):150-63. PubMed ID: 3491754
    [Abstract] [Full Text] [Related]

  • 24. Modulation of the immune response by anaphylatoxin in the microenvironment of the interacting cells.
    Weigle WO, Morgan EL, Goodman MG, Chenoweth DE, Hugli TE.
    Fed Proc; 1982 Dec; 41(14):3099-103. PubMed ID: 6216123
    [Abstract] [Full Text] [Related]

  • 25. Activation of human serum complement with allergens. I. Generation of C3a, C4a, and C5a and induction of human neutrophil aggregation.
    Nagata S, Glovsky MM.
    J Allergy Clin Immunol; 1987 Jul; 80(1):24-32. PubMed ID: 3496373
    [Abstract] [Full Text] [Related]

  • 26. Interaction of C3 with antigen-antibody complexes in the process of solubilization of immune precipitates.
    Takata Y, Tamura N, Fujita T.
    J Immunol; 1984 May; 132(5):2531-7. PubMed ID: 6232320
    [Abstract] [Full Text] [Related]

  • 27. Inhibition of immune precipitation by complement.
    Schifferli JA, Bartolotti SR, Peters DK.
    Clin Exp Immunol; 1980 Nov; 42(2):387-94. PubMed ID: 6781802
    [Abstract] [Full Text] [Related]

  • 28. Complement activation and impaired capacity to solubilize immune complexes or to prevent their formation in essential mixed cryoglobulinemia.
    Corvetta A, Spaeth PJ, Ghirelli PA, Orecchioni F, Buetler R, Montroni M, Nydegger UE.
    Diagn Immunol; 1983 Nov; 1(4):315-23. PubMed ID: 6333960
    [Abstract] [Full Text] [Related]

  • 29. Serum complement levels and severity of sepsis.
    Nakae H, Endo S, Inada K, Takakuwa T, Kasai T, Yoshida M.
    Res Commun Chem Pathol Pharmacol; 1994 May; 84(2):189-95. PubMed ID: 8091004
    [Abstract] [Full Text] [Related]

  • 30. Comparative study on biological activities of various anaphylatoxins (C4a, C3a, C5a). Investigations on their ability to induce platelet secretion.
    Meuer S, Hugli TE, Andreatta RH, Hadding U, Bitter-Suermann D.
    Inflammation; 1981 Dec; 5(4):263-73. PubMed ID: 6976935
    [Abstract] [Full Text] [Related]

  • 31. [Immunological tests: Anaphylatoxins C3a, C4a, C5a].
    Fujino S, Sakurabayashi I.
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():80-3. PubMed ID: 16111194
    [No Abstract] [Full Text] [Related]

  • 32. Demonstration of anaphylatoxins C3a, C4a and C5a in the scales of psoriasis and inflammatory pustular dermatoses.
    Takematsu H, Ohkohchi K, Tagami H.
    Br J Dermatol; 1986 Jan; 114(1):1-6. PubMed ID: 3484631
    [Abstract] [Full Text] [Related]

  • 33. Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes.
    Chenoweth DE, Cheung AK, Henderson LW.
    Kidney Int; 1983 Dec; 24(6):764-9. PubMed ID: 6609269
    [Abstract] [Full Text] [Related]

  • 34. Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin.
    Kievits F, Kijlstra A.
    Immunology; 1985 Mar; 54(3):449-56. PubMed ID: 3844370
    [Abstract] [Full Text] [Related]

  • 35. The structural basis for anaphylatoxin and chemotactic functions of C3a, C4a, and C5a.
    Hugli TE.
    Crit Rev Immunol; 1981 Feb; 1(4):321-66. PubMed ID: 7037298
    [No Abstract] [Full Text] [Related]

  • 36. Effect of exercise on complement activity.
    Smith JK, Chi DS, Krish G, Reynolds S, Cambron G.
    Ann Allergy; 1990 Oct; 65(4):304-10. PubMed ID: 2221489
    [Abstract] [Full Text] [Related]

  • 37. Pulmonary injury induced by C3a and C5a anaphylatoxins.
    Stimler NP, Hugli TE, Bloor CM.
    Am J Pathol; 1980 Aug; 100(2):327-48. PubMed ID: 6967702
    [Abstract] [Full Text] [Related]

  • 38. Anaphylatoxin-mediated regulation of human and murine immune responses.
    Morgan EL, Weigle WO, Hugli TE.
    Fed Proc; 1984 Jul; 43(10):2543-7. PubMed ID: 6610569
    [Abstract] [Full Text] [Related]

  • 39. The role of C1, C1-inactivator and C4 in modulating immune precipitation.
    Schifferli JA, Steiger G, Schapira M.
    Clin Exp Immunol; 1985 Jun; 60(3):605-12. PubMed ID: 4017288
    [Abstract] [Full Text] [Related]

  • 40. Prevention of immune precipitation by purified classical pathway complement components.
    Naama JK, Hamilton AO, Yeung-Laiwah AC, Whaley K.
    Clin Exp Immunol; 1984 Nov; 58(2):486-92. PubMed ID: 6333948
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.